RPG Life Sciences (NSE:RPGLIFE) Moat Score: 0/10 (As of Jul. 11, 2026)


NSE:RPGLIFE RPG Life Sciences Ltd NSE:RPGLIFE
88 GF Score
Price ₹2,856.90
GF Value ₹2,356.49
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is RPG Life Sciences Moat Score?

RPG Life Sciences has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

RPG Life Sciences has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes RPG Life Sciences might have No Moat - No discernible moat.

RPG Life Sciences  (NSE:RPGLIFE) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

RPG Life Sciences Moat Score Related Terms

NSE:RPGLIFE
88GF Score
RPG Life Sciences Ltd NSE:RPGLIFE
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued. The current stock price of ₹2,856.90 is trading 21.2% above its estimated GF Value™ of ₹2,356.49. GuruFocus considers RPG Life Sciences to be Modestly Overvalued.

Key valuation signals for NSE:RPGLIFE:

  • Moat Score: 0
  • GF Value™: ₹2,356.49 vs. price of ₹2,856.90 (21.2% above fair value)
  • GF Score™: 88/100 with 6 warning signs

No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RPG Life Sciences Business Description

Other Exchanges 532983:India
Address 463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
88GF Score

Get the complete analysis for NSE:RPGLIFE

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,856.90
Price
₹2,356.49
GF Value